Xiaojie Liu , Junru Liu , Lyuye Liu , Jipeng Yu , Dejing Gao , Tianyuan Zhou , Weibin Xing
{"title":"电干燥联合光动力疗法治疗高危基底细胞癌的疗效及实证分析。","authors":"Xiaojie Liu , Junru Liu , Lyuye Liu , Jipeng Yu , Dejing Gao , Tianyuan Zhou , Weibin Xing","doi":"10.1016/j.pdpdt.2025.104730","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Basal cell carcinoma (BCC) is the most common non-pigmented cutaneous malignancy.ALA-PDT has significant advantages in the treatment of BCC, but it is limited by the size and depth of the tumor. Combination therapy can improve the efficacy of PDT in treating BCC and overcome its limitations.</div></div><div><h3>Methods</h3><div>A retrospective study was conducted to analyze the feasibility of ET combined with ALA-PDT in the treatment of high-risk BCC in terms of efficacy, aesthetic outcome, patient satisfaction, quality of life, and adverse reactions.</div></div><div><h3>Results</h3><div>High-risk BCC treated with ET combined with ALA-PDT showed a cure rate of 98.55 % and a recurrence rate of 1.45 % at 1 year or more (average follow-up of 31 months). The treatment showed excellent aesthetic results (scar score of 1.87) and high patient satisfaction (8.03). The quality of life of the treated patients significantly improved compared to the pre-treatment period (DLQI of 13.03 and 1.94 points), and the difference was statistically significant. The average healing time was 16.81 days after treatment. The main adverse reactions were moderate pain (4.90 points) and local redness and swelling, and no infection was observed.</div></div><div><h3>Conclusion</h3><div>ET combined with PDT showed remarkable efficacy in the treatment of high-risk BCC. The combination provides rapid healing, less scarring, and good aesthetic outcomes, which can be used as a clinical choice for treating high-risk BCC. However, it still needs to be verified in studies with larger sample sizes and longer follow-up periods.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"55 ","pages":"Article 104730"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and empirical analysis of electrodesiccation combined with photodynamic therapy in the treatment of high-risk basal cell carcinoma\",\"authors\":\"Xiaojie Liu , Junru Liu , Lyuye Liu , Jipeng Yu , Dejing Gao , Tianyuan Zhou , Weibin Xing\",\"doi\":\"10.1016/j.pdpdt.2025.104730\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Basal cell carcinoma (BCC) is the most common non-pigmented cutaneous malignancy.ALA-PDT has significant advantages in the treatment of BCC, but it is limited by the size and depth of the tumor. Combination therapy can improve the efficacy of PDT in treating BCC and overcome its limitations.</div></div><div><h3>Methods</h3><div>A retrospective study was conducted to analyze the feasibility of ET combined with ALA-PDT in the treatment of high-risk BCC in terms of efficacy, aesthetic outcome, patient satisfaction, quality of life, and adverse reactions.</div></div><div><h3>Results</h3><div>High-risk BCC treated with ET combined with ALA-PDT showed a cure rate of 98.55 % and a recurrence rate of 1.45 % at 1 year or more (average follow-up of 31 months). The treatment showed excellent aesthetic results (scar score of 1.87) and high patient satisfaction (8.03). The quality of life of the treated patients significantly improved compared to the pre-treatment period (DLQI of 13.03 and 1.94 points), and the difference was statistically significant. The average healing time was 16.81 days after treatment. The main adverse reactions were moderate pain (4.90 points) and local redness and swelling, and no infection was observed.</div></div><div><h3>Conclusion</h3><div>ET combined with PDT showed remarkable efficacy in the treatment of high-risk BCC. The combination provides rapid healing, less scarring, and good aesthetic outcomes, which can be used as a clinical choice for treating high-risk BCC. However, it still needs to be verified in studies with larger sample sizes and longer follow-up periods.</div></div>\",\"PeriodicalId\":20141,\"journal\":{\"name\":\"Photodiagnosis and Photodynamic Therapy\",\"volume\":\"55 \",\"pages\":\"Article 104730\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photodiagnosis and Photodynamic Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1572100025002625\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodiagnosis and Photodynamic Therapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1572100025002625","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Efficacy and empirical analysis of electrodesiccation combined with photodynamic therapy in the treatment of high-risk basal cell carcinoma
Background
Basal cell carcinoma (BCC) is the most common non-pigmented cutaneous malignancy.ALA-PDT has significant advantages in the treatment of BCC, but it is limited by the size and depth of the tumor. Combination therapy can improve the efficacy of PDT in treating BCC and overcome its limitations.
Methods
A retrospective study was conducted to analyze the feasibility of ET combined with ALA-PDT in the treatment of high-risk BCC in terms of efficacy, aesthetic outcome, patient satisfaction, quality of life, and adverse reactions.
Results
High-risk BCC treated with ET combined with ALA-PDT showed a cure rate of 98.55 % and a recurrence rate of 1.45 % at 1 year or more (average follow-up of 31 months). The treatment showed excellent aesthetic results (scar score of 1.87) and high patient satisfaction (8.03). The quality of life of the treated patients significantly improved compared to the pre-treatment period (DLQI of 13.03 and 1.94 points), and the difference was statistically significant. The average healing time was 16.81 days after treatment. The main adverse reactions were moderate pain (4.90 points) and local redness and swelling, and no infection was observed.
Conclusion
ET combined with PDT showed remarkable efficacy in the treatment of high-risk BCC. The combination provides rapid healing, less scarring, and good aesthetic outcomes, which can be used as a clinical choice for treating high-risk BCC. However, it still needs to be verified in studies with larger sample sizes and longer follow-up periods.
期刊介绍:
Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.